ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1077

Pragmatic Quantitative Rheumatologist 0–10 Visual Numeric Scale Estimates of Inflammation, Damage, and Patient Distress Have Face Validity and May Be as Informative as Formal 28 Joint Counts in Rheumatoid Arthritis

Theodore Pincus1, tengfei Li2 and Juan Schmukler1, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, washington dc

Meeting: ACR Convergence 2024

Keywords: Back pain, depression, fibromyalgia, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: A 28 joint count of swelling (SJC), tenderness/pain on motion (TJC), and deformity/limited motion (DJC), is recommended to assess rheumatoid arthritis (RA) patient status. However, most visits of most RA patients do not include formal joint counts unless required for therapies.  Furthermore, most current routine care and long-term databases omit DJC, which is unlikely to change with anti-inflammatory therapies, but which indicates progression and poorer patient status over 5 years, while SJC and TJC were unchanged (Arth Care Res. 1997;10:381).  Another approach  to assess RA patient status is for rheumatologists to estimate three 0–10 visual numeric scales (VNS) for inflammation (DOCINF), joint damage (DOCDAM), and patient distress (DOCDIS), in addition to physician global assessment (DOCGL), which requires 30 seconds compared to 90 seconds for formal joint counts. We compared SJC, TJC and DJC to DOCINF, DOCDAM, and DOCDIS in a cross -sectional study of RA patients with long disease duration.

Methods: A retrospective analysis was conducted of a cross-sectional study performed at a routine visit of RA patients which included 28 joint counts, (26 for SJC as shoulder swelling is not included), TJC and DJC, as well as a physician RheuMetric checklist to estimate DOCGL, DOCINF, DOCDAM, and DOCDIS.  Cross-tabulations of SJC, TJC, and DJC as 0 or 1 vs ≥2, and DOCGL, DOCINF, DOCDAM, and DOCDIS as 0-2, 2.1-4, and >4 were analyzed using chi-square tests.

Results: The study included 173 patients with a median age of 61.3, and median disease duration of 10.0 years. Mean and median SJC were 1.7 and 0, TJC 3.8 and 2, DJC 5.4 and 4, DOCGL 3.7 and 3.5, DOCINF 1.5 and 1.0, DOCDAM 3.2 and 3.0 and DOCDIS 2.4 and 1.0, respectively.  Two or more abnormal joints were seen in 29% of patients for SJC, 53% for TJC and 62% for DJC (Table). These findings indicate excellent control of inflammatory activity in current rheumatology care, as joint damage was more prominent than inflammation and patient distress in these RA patients managed over long periods.  Overall, 47% of patients with 0 or 1 SJC had DOCGL 0–2 compared to 89% with DOCINF 0-2, 44% with DOCDAM 0-2 and 67% with DOCDIS 0-2 (Table).  All comparisons of patients with TJC with DOCGL, DOCINF, DOCDAM, and DOCDIS were statistically significant, as TJC may indicate inflammatory activity, as well as joint damage and patient distress (Table).  DJC was statistically significant only in comparisons with DOCDAM,  Indicating specificity (Table).  These data appear consistent with clinical observations and suggest face validity.   Scoring of DOCGL, DOCINF, DOCDAM and DOCDIS required 25-30 seconds.

Conclusion: In RA patients with median disease duration of 10 years, TJC and DJC were higher than SJC, and DOCDAM and DOCDIS were higher than DOCINF, suggesting that joint damage and patient distress should be assessed in addition to inflammation in long-term clinical care of RA.  DOCGL, DOCINF, DOCDAM and DOCDIS provide pragmatic quantitative assessment for routine care. 

Supporting image 1


Disclosures: T. Pincus: Medical History Services LLC, 9, 10; t. Li: None; J. Schmukler: None.

To cite this abstract in AMA style:

Pincus T, Li t, Schmukler J. Pragmatic Quantitative Rheumatologist 0–10 Visual Numeric Scale Estimates of Inflammation, Damage, and Patient Distress Have Face Validity and May Be as Informative as Formal 28 Joint Counts in Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pragmatic-quantitative-rheumatologist-0-10-visual-numeric-scale-estimates-of-inflammation-damage-and-patient-distress-have-face-validity-and-may-be-as-informative-as-formal-28-joint-counts-i/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pragmatic-quantitative-rheumatologist-0-10-visual-numeric-scale-estimates-of-inflammation-damage-and-patient-distress-have-face-validity-and-may-be-as-informative-as-formal-28-joint-counts-i/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology